This page shows the latest celecoxib news and features for those working in and with pharma, biotech and healthcare.
Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex (celecoxib) last December in the US, with competition already being felt
courts. Several generic pharma companies have been planning to launch copycat versions of Celebrex (celecoxib) in the US on May 30, when the basic patent on the active ingredient of the
There were also gains for anti-inflammatory Celebrex (celecoxib), up 11 per cent to $752m, while fibromyalgia drug Lyrica (pregabalin) cemented its position as Pfizer's biggest-selling product with a
Epilepsy, neuropathic pain and fibromyalgia therapy Lyrica (pregabalin) cemented its position as Pfizer's biggest product with a 10 per cent gain to $1.13bn, while painkiller Celebrex (celecoxib) grew 10
to faking dozens of research studies, including trials of Pfizer's Celebrex (celecoxib) and Merck &Co's Vioxx (rofecoxib).
Celebrex (celecoxib) remains a major product for Pfizer, with global sales growing 9 per cent to $2.7bn last year, mainly as a treatment for osteoarthritis. ... We are pleased with the reissuance of this patent protecting the invention of using celecoxib
More from news
Approximately 3 fully matching, plus 14 partially matching documents found.
During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...